CiteULike: guhjy's Travert:F [4 articles]

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.

Diabetes care, Vol. 32, No. 11. (3 November 2009), pp. 2068-2074.

posted to uae perindopril glycemia dn dm cv bp advance by guhjy on 2009-09-07 11:02:29 as

along with 1 person booker

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

Diabetologia, Vol. 52, No. 11. (1 November 2009), pp. 2288-2298.

by F. M. Turnbull, C. Abraira, R. J. Anderson, et al.R. P. Byington, J. P. Chalmers, W. C. Duckworth, G. W. Evans, H. C. Gerstein, R. R. Holman, T. E. Moritz, B. C. Neal, T. Ninomiya, A. A. Patel, S. K. Paul, F. Travert, M. Woodward

posted to rct glycemia dm cv by guhjy on 2009-09-07 11:01:37 as

along with 2 people booker omalbam

Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies.

Diabetes care, Vol. 31, No. 9. (September 2008), pp. 1847-1852.

by S. Hadjadj, F. Fumeron, R. Roussel, et al.P. J. Saulnier, Y. Gallois, A. Ankotche, F. Travert, C. Abi Khalil, A. Miot, F. Alhenc-Gelas, M. Lievre, M. Marre, , ,

posted to ace dm dn snp by guhjy on 2008-09-09 05:08:27 as

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

The New England journal of medicine, Vol. 358, No. 24. (12 June 2008), pp. 2560-2572.

posted to rct glycemia dm cv advance by guhjy on 2008-06-14 13:53:45 as

along with 7 people ggrassi eplingj nm61591 timsenior booker djmonstermo omalbam

Sort by:
Order:	Default Ascending Descending
Empty fields:	Default First Last

	Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial. [My Copy] Diabetes care, Vol. 32, No. 11. (3 November 2009), pp. 2068-2074. by Sophia Zoungas, Bastiaan E. de Galan, Toshiharu Ninomiya, et al.Diederick Grobbee, Pavel Hamet, Simon Heller, Stephen MacMahon, Michel Marre, Bruce Neal, Anushka Patel, Mark Woodward, John Chalmers, ADVANCE Collaborative Group, Alan Cass, Paul Glasziou, Stephen Harrap, Liu Lisheng, Guiseppe Mancia, Avinesh Pillai, Neil Poulter, Vlado Perkovic, Florence Travert posted to uae perindopril glycemia dn dm cv bp advance by guhjy on 2009-09-07 11:02:29 as along with 1 person booker
	Intensive glucose control and macrovascular outcomes in type 2 diabetes. [My Copy] Diabetologia, Vol. 52, No. 11. (1 November 2009), pp. 2288-2298. by F. M. Turnbull, C. Abraira, R. J. Anderson, et al.R. P. Byington, J. P. Chalmers, W. C. Duckworth, G. W. Evans, H. C. Gerstein, R. R. Holman, T. E. Moritz, B. C. Neal, T. Ninomiya, A. A. Patel, S. K. Paul, F. Travert, M. Woodward posted to rct glycemia dm cv by guhjy on 2009-09-07 11:01:37 as along with 2 people booker omalbam
	Prognostic value of the insertion/deletion polymorphism of the ACE gene in type 2 diabetic subjects: results from the Non-insulin-dependent Diabetes, Hypertension, Microalbuminuria or Proteinuria, Cardiovascular Events, and Ramipril (DIABHYCAR), Diabete de type 2, Nephropathie et Genetique (DIAB2NEPHROGENE), and Survie, Diabete de type 2 et Genetique (SURDIAGENE) studies. [My Copy] Diabetes care, Vol. 31, No. 9. (September 2008), pp. 1847-1852. by S. Hadjadj, F. Fumeron, R. Roussel, et al.P. J. Saulnier, Y. Gallois, A. Ankotche, F. Travert, C. Abi Khalil, A. Miot, F. Alhenc-Gelas, M. Lievre, M. Marre, , , posted to ace dm dn snp by guhjy on 2008-09-09 05:08:27 as
	Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. [My Copy] The New England journal of medicine, Vol. 358, No. 24. (12 June 2008), pp. 2560-2572. by ADVANCE Collaborative Group, Anushka Patel, Stephen MacMahon, et al.John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee, Pavel Hamet, Stephen Harrap, Simon Heller, Lisheng Liu, Giuseppe Mancia, Carl Erik E. Mogensen, Changyu Pan, Neil Poulter, Anthony Rodgers, Bryan Williams, Severine Bompoint, Bastiaan E. de Galan, Rohina Joshi, Florence Travert posted to rct glycemia dm cv advance by guhjy on 2008-06-14 13:53:45 as along with 7 people ggrassi eplingj nm61591 timsenior booker djmonstermo omalbam

guhjy's Travert:F [4 articles] Export Sort

guhjy's tags

ckd	1742
rct	1205
dn	1167
dm	1070
cancer	1068
ma	979
cv	933
hd	859
tgfb	857
snp	772
ros	705
bp	645
kidney	529
meta-analysis	516
mouse	508
uae	501
stats	480
software	466
pt	456
mirna	450
genetics	450
proteomics	414
mortality	411
rat	401
1	389
fbl	386
inflammation	378
tw	378
mtor	363
proteinuria	356
pcr	353
mc	351
akt	350
method	340
db	337
acei	335
gdl	332
irs	332
inhibitor	329
test	325
urine	320
apoptosis	320
arb	318
age	317
aging	315
ms	311
aii	310
hcv	308
r	294
hg	292
biomarker	287
pi3k	283
ppi	282
bias	278
bayes	275
aki	272
gwa	270
emt	268
s6k	266
rnai	257
nutrition	255
egfr	253
ub	248
p53	246
fibrosis	242
erk	238
obesity	236
smad	234
cox	229
drug	225
pbmc	223
hcc	217
hypoxia	216
metab	214
gn	210
nfkb	209
herb	204
stz	199
collagen	197
albumin	189
lc	187
hif	187
pkc	181
longitudinal	179
pubmed	179
lmm	178
p38	176
gfr	175
ua	171
epigenetics	169
bioinf	167
japan	166
cea	163
power	163
dna-damage	162
rage	162
gender	162
lead	160
book	160
cadmium	159
genomics	155
ref	152
ctgf	150
vitamin-d	149
stata	147
liver	147
company	146
mt	146
network	146
diet	138
screening	137
rt	136
phosphorylation	135
seq	133
no	132
stat	129
insulin	129
kinase	128
esrd	128
cell-cycle	128
go	128
protein	127
pathway	127
systems-biology	124
statin	121
lipid	119
creatinine	117
proliferation	113
senescence	112
gene-therapy	110
nox	109
podocyte	109
mapk	109
tnf	107
imaging	107
fish	104
p21	104
hypertrophy	104
regression	103
cad	103
pd	102
pparg	102
case-control	102
gfr-formula	102
imputation	101
multiplicity	100
ampk	100
at1	98
plasmid	98
observational	98
ko	97
sirt	97
methylation	96
pediatric	96
cloning	96
rx	96
recurrent	94
src	93
blood	93
betel	93
review	92
chf	92
nhanes	91
immunity	89
website	89
anemia	89
phenotype	88
diagnosis	87
autophagy	87
lr	86
toxicology	86
uti	85
epo	84
cytokine	84
ebm	84
china	83
environment	82
ca	82
p	82
oat	81
nonp	81
cachexia	81
hapmap	80
gout	80
primer	78
qms	77
signaling	76
egf	75
col4	74
promoter	74
foxo	74
gpcr	73
missing	73
ace	73
eif	73
hts	72
surrogate	72
4ebp	72
cox2	72
stone	72
lpd	72
gene-list	72
eqtl	72
mv	71
p-value	71
jnk	70
phd	70
salt	70
mgo	69
metformin	69
glycemia	68
uuo	67
uncertainty	66
enddysf	65
translation	65
ifn	65
mirna-target	65
normalization	65
tin	65
chinese	65
pe	65
pla2	64
hsp	64
association	64
shc	64
llcpk1	63
causation	63
2dge	63
yeast	63
acid-base	63
me	62
smoking	62
pai1	62
nrk49f	62
simulation	62
pdgf	62
oglcnac	61
avf	61
mmp	61
ptm	61
vegf	61
confounding	61
pld	60
hk2	60
infection	60
cost	60
crp	60
melamine	60
outcome	60
sas	60
oral	60
change	60
rho	58
alcohol	58
fluorescence	58
iron	58
model-selection	57
rapamycin	57
cyclin-d1	57
urate-transporter	57
pls	57
robust	57
aceiarb	56
semantic	56
achr	56
calibration	56
stem-cell	55
estrogen	55
goldstd	55
ace2	55
ncrna	55
ratio	55
competing-risk	55
bone	54
workflow	54
ckd-progression	54
function	54
p27	53
renoprotection	53
std	53
il6	53
hsc	53
dipstick	53
k	53
tf	52
atm	52
histone	52
hdac	52
dimerization	52
qc	52
fgf	52
lod	51
ab	51
hepatocyte	51
normoalbuminuria	51
pth	51
epidemiology	51
matlab	50
reasoning	50
risk-ratio	50
graph	50
mercury	50
arsenic	50
adpkd	50
wnt	50
klotho	49
pdk	49
gene-environment	49
antibiotics	49
epistasis	49
breakpoint	48
irs1	48
ukm	48
nrk52e	48
core-curriculum	48
ngal	48
ffpe	48
endothelium	48
ras	47
aldosterone	47
spot-urine	47
joint-model	47
pooling	47
enos	47
mtorc1	47
fdr	46
er-stress	46
dub	46
cystatin	46
hgf	46
aspirin	46
metal	46
protein-microarray	46
semip	45
fgf23	45
ecm	45
writing	45
tgfbr	45
biosensor	45
prevention	45
dbdb	45
ccb	44
sumo	44
interaction	44
ancova	44
mesangial	44
variability	44
diuretics	44
cnv	43
bia	43
design	43
klf	43
sle	43
na	43
asia	42
roc	42
good	42
agreement	42
stroke	42
fibronectin	42
icu	42
vsmc	42
catenin	42
bmi	42
fuzzy	41
proteasome	41
gene-targeting	41
qtl	41
ap1	40
alignment	40
tea	40
sage	40
wga	40
hyperfiltration	40
risk	40
tlr	40
dry-bw	39
rca	39
protein-complex	39
angiogenesis	39
coffee	39
antisense	39
urinalysis	39
igf	39
rsk	39
emr	38
myc	38
igan	38
rvh	38
mtorc2	38
gsk3	38
omics	38
fabp	37
adenosine	37
gsk	37
haplotype	37
hematuria	37
megalin	37
snx	37
bh4	37
propensity	37
glut	37
adh	37
il1	36
animal	36
s100b	36
web20	36
exercise	36
cardiorenal	36
inflammasome	36
threshold	35
sp1	35
cre	35
candidate-gene	35
annotation	35
calcification	35
reverse-epidemiology	35
creb	35
subgroup	35
adduct	35
chemogenomics	35
pka	35
nephrotoxicity	34
attrition	34
igf1	34
effect-size	34
sepsis	34
pathology	34
msm	34
pp2a	34
cross-species	34
sglt	34
ns	33
zeb	33
ecology	33
rtk	33
sarcopenia	33
integrin	33
bmp	33
cage	33
et	33
orbitrap	32
addgene	32
aa	32
set	32
steroid	32
zfn	32
browser	32
affy	32
fc	32
text-mining	32
end-point	32
macrophage	32
ai	32
gsh	31
hospitalization	31
silac	31
family	31
gllamm	31
risk-difference	31
blast	31
emsa	31
transactivation	31
agt	31
reporter	31
nutrient	31
acidosis	31
cr	31
abp	31
frailty	31
heritability	31
staging	30
pten	30
geo	30
membrane-protein	30
notch	30
s100	30
transporter	30
knockout	30
grn	30
mw	30
carcinogen	30
nicotinic	29
3	29
perindopril	29
thesis	29
human	29
virus	29
validation	29
sgk	29
extraction	29
ub-ligase	29
renin	29
muscarinic	28
jun	28
scaling	28
pharmacogenetics	28
acetylation	28
time-dependent	28